| Fund ID | 805-6659495318 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | Yes |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 85% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Dafna Lifescience, L.P. | Hedge | $385.7M |
| Dafna Fund, L.P. Series a | Hedge | $217M |
| Dafna International Fund Ltd. Class a | Hedge | $165.1M |
Dafna Fund, L.P. Series C reports $120.6 million in gross assets, among the top 39% of private funds by size.
The stated minimum investment is $1 million.
Dafna Fund, L.P. Series C is managed by Dafna Capital Management, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.